日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

口服索马鲁肽对高危 2 型糖尿病患者心血管危险因素的影响:SOUL 随机临床试验的事后二次分析

Mulvagh, Sharon L; Inzucchi, Silvio E; Marx, Nikolaus; Poulter, Neil R; Deanfield, John E; Pop-Busui, Rodica; Emerson, Scott S; Mann, Johannes F E; Engelmann, Mads D M; Hovingh, G Kees; Mandavya, Kabirdev; Davicevic-Elez, Zaklina; Jeppesen, Ole Kleist; Lorenzatti, Alberto; Oguz, Aytekin; Mankovsky, Boris; Deerochanawong, Chaicharn; Gorgojo-Martinez, Juan J; Ji, Linong; Bain, Stephen C; McGuire, Darren K; Buse, John B

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial

口服索马鲁肽对2型糖尿病患者肾脏结局的影响:SOUL随机试验的结果

Mann, Johannes F E; Marx, Nikolaus; Deanfield, John E; Emerson, Scott S; Inzucchi, Silvio E; McGuire, Darren K; Mulvagh, Sharon L; Pop-Busui, Rodica; Poulter, Neil R; Engelmann, Mads D M; Hovingh, G Kees; Belmar, Nicolas; Idorn, Thomas; Jeppesen, Ole Kleist; Birkenfeld, Andreas L; Amod, Aslam; Mankovsky, Boris; Desouza, Cyrus; Gorgojo-Martinez, Juan J; Arechavaleta, Rosario; Tu, Shih-Te; Buse, John B

Response to comments on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 2025;48:2145-2153

对 Pop-Busui 等人发表的题为“筛查利钠肽水平可预测无已知心力衰竭的 1 型和 2 型糖尿病患者的心力衰竭和死亡”的文章的评论的回应。Diabetes Care 2025;48:2145-2153

Pop-Busui, Rodica; Repetto, Enrico; Baron, Jason; Schumacher, Dagmar; Vaduganathan, Muthiah; Pandey, Ambarish

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

口服索马鲁肽对 2 型糖尿病患者心力衰竭结局的影响:SOUL 随机临床试验的二次分析

Pop-Busui, Rodica; Rasmussen, Søren; Deanfield, John E; Buse, John B; Marx, Nikolaus; Mulvagh, Sharon L; Inzucchi, Silvio E; Mann, Johannes F E; Emerson, Scott S; Poulter, Neil R; Engelmann, Mads D M; Hovingh, G Kees; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L; Connelly, Kim A; Haluzik, Martin; Cavender, Matthew A; Kellerer, Monika; Jhund, Pardeep S; Gregersen, Søren; Nielsen, Olav Wendelboe; Lam, Carolyn S P; McGuire, Darren K

Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

根据SGLT2i的使用情况,口服索马鲁肽对2型糖尿病患者心血管结局的影响:SOUL随机试验的预设分析

Marx, Nikolaus; Deanfield, John E; Mann, Johannes F E; Arechavaleta, Rosario; Bain, Stephen C; Bajaj, Harpreet S; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L; Buse, John B; Davicevic-Elez, Zaklina; Desouza, Cyrus; Emerson, Scott S; Engelmann, Mads D M; Hovingh, G Kees; Inzucchi, Silvio E; Jhund, Pardeep S; Mulvagh, Sharon L; Pop-Busui, Rodica; Poulter, Neil R; Rasmussen, Søren; Tu, Shih-Te; McGuire, Darren K

Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial

降血糖药物、血糖和认知结果:GRADE随机临床试验

Luchsinger, José A; Rosin, Samuel P; Kazemi, Erin J; Younes, Naji; Suratt, Colleen E; Fattaleh, Basma N; Florez, Hermes J; Gonzalez, Jeffrey S; Hollander, Priscilla; Hox, Sophia H; Kuo, Shihchen; Lee, Melissa S; Martens, Thomas; Pop-Busui, Rodica; Seaquist, Elizabeth R; Waltje, Andrea H; Barzilay, Joshua I

Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes

一项针对1型糖尿病患者的纵向队列研究表明,以心率变异性指标定义的自主神经病变与心血管疾病相关:

Braffett, Barbara H; El Ghormli, Laure; Martin, Catherine; White, Neil H; Hirsch, Irl B; Bantle, Anne; Carlson, Anders; Leschek, Ellen; Gubitosi-Klug, Rose; Soliman, Elsayed Z; Vella, Adrian; Perkins, Bruce A; Bebu, Ionut; Pop-Busui, Rodica

Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney Disease

在1型糖尿病合并糖尿病肾病患者人群中,利用细胞外液容量而非体表面积对肾小球滤过率进行指数化

Sridhar, Vikas S; Kugathasan, Luxcia; Lovblom, Leif Erik; Huajing, Ni; Lanctot, Sebastien O; Maahs, David M; Bjornstad, Petter; Caramori, M Luiza; Rosas, Sylvia E; Rossing, Peter; Tuttle, Katherine R; Pop-Busui, Rodica; Polsky, Sarit; Karger, Amy B; Wu, Chunyi; Galecki, Andrzej T; Perkins, Bruce A; Mauer, Michael; Doria, Alessandro; Cherney, David Z I

Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus

蛋白尿和肾功能快速下降是1型糖尿病肾脏临床试验的选择标准

Keum, Youngshin; Caramori, Maria Luiza; Cherney, David Z; Crandall, Jill P; de Boer, Ian H; Lingvay, Ildiko; McGill, Janet B; Polsky, Sarit; Pop-Busui, Rodica; Rossing, Peter; Sigal, Ronald J; Mauer, Michael; Doria, Alessandro

Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial

美国心脏病诊所中接受SGLT-2抑制剂和/或GLP-1受体激动剂治疗的患者特征:来自COORDINATE-diabetes试验的启示

Nelson, Adam J; Kaltenbach, Lisa A; Al-Khalidi, Hussein R; Leyva, Monica; Webb, Laura; McGuire, Darren K; Pop-Busui, Rodica; Cavender, Matthew A; Aroda, Vanita R; Magwire, Melissa L; Richardson, Caroline R; Lingvay, Ildiko; Kirk, Julienne K; Pandey, Ambarish; Gaynor, Tanya; Pak, Jonathan; Washington, Alana; Senyucel, Cagri; Lopes, Renato D; Green, Jennifer B; Granger, Christopher B; Pagidipati, Neha J